@whitewadenumber3 After complete (R0) esophagogastrectomy (Ivor-Lewis/Garlock) and adjuvant/neoadjuvant chemoimmunradiotherapy 5-year survival of esophageal cancer patients with stage T3N0M0 reaches 65-70%.
5-year survival of esophageal cancer patients after radical esophagogastrectomies is 50%, 10-year survival - 38%, for cardioesophageal cancer patients 5-year survival - 36%, 10-year survival - 27%.
OK, no problem! It is absolutely indifferent to me what is patients from. I will try to help everybody owing to my possibilities, features of a pathology and resources of the patient' organism.
Yes, sure! Esophageal and cardioesophageal cancer surgery demands masterly, precise and aggressive surgical technique, especially for cancer with stage T3-4N0-M1A and always will remain privilege of very experienced surgeons. Actual surgical removal of tumor and lymph node metastases remains basic management of this very aggressive cancer giving real chance for cure in spite of extensive research over last 30 years in terms of chemotherapy, radiotherapy, immuno- and gene therapy.
I advise to read 2 articles of Kshivets regarding esophageal & cardioesophageal cancer treatment on the Internet: The Open Cardiovascular and Thoracic Surgery Journal
I like VATS, robotic and transhiatal esophagectomies which are optimal for early cancer and adequate in absence of N1 (stage I-IIA: T2-3N0). But these procedures are insufficient for stage IIB-IVA because of problems with lymphadenectomy, etc. Here Ivor-Lewis and Garlock procedures are optimal. Regarding local advanced esophageal/ cardioesophageal cancer it is quite clear: only Ivor-Lewis and Garlock, usually combined, which demand faultless surgical technics and personal wide experience.
I know that Dr. Kshivets is the expert regarding esophagus cancer. May I ask question to Dr. Kshivets: What about minimal invasive and transchiatal esophagectomy for esophagus cancer?
Yes, I agree with comment. Esophageal and cardioesophageal cancer increased by 500% in last 30 years, but total 5-year survival is only 4% (USA). 80-90% patients with this cancer have already advanced cancer. Only several best surgeons in the world are capable to fulfil such operations successfully.
Patients with esophageal cancer with stage IVA live several weeks and die from haemorrhage, generalization, cachexia in spite of chemiotherapy and radiotherapy.
can u please let me have a video where u r giving incisions for the ivor lewis approach?
asadkamranshaikh 1 year ago
Chance of survival of a T3n0m0 patient after surgery and chemoradiation before surgery
whitewadenumber3 1 year ago 11
@whitewadenumber3 After complete (R0) esophagogastrectomy (Ivor-Lewis/Garlock) and adjuvant/neoadjuvant chemoimmunradiotherapy 5-year survival of esophageal cancer patients with stage T3N0M0 reaches 65-70%.
Kshivets002 1 year ago 56
@Kshivets002 would you say the outcome is better if chemoradiation therapy is administered adjuvantly or neoadjuvantly?
whitewadenumber3 1 year ago 9
@whitewadenumber3 I prefer adjuvant chemoimmunoradiotherapy for patients with stage T1-4N0-1M1A.
Kshivets002 1 year ago 50
Dear Dr. Oleg Kshivets: may we send our patients with cardioesophageal & esophageal cancer (lower, middle, upper third) from Israel?
israelclinics 1 year ago 134
@israelclinics OK! Send patients with stage T1-4N1MA (without distant metastases) in excellent physical condition.
Kshivets002 1 year ago 21
5-year survival of esophageal cancer patients after radical esophagogastrectomies is 50%, 10-year survival - 38%, for cardioesophageal cancer patients 5-year survival - 36%, 10-year survival - 27%.
Kshivets002 1 year ago 397
What about 5-year survival after complete esophagogastrectomies?
tsukubaj 1 year ago 34
Postoperative mortality after Lewis & Garlock esophagogastrectomies is less 2%.
Kshivets002 1 year ago 376
What about postoperative mortality after esophagogastrectomies Ivor-Lewis and Garlock?
mayochestsurgery 1 year ago 36
OK, no problem! It is absolutely indifferent to me what is patients from. I will try to help everybody owing to my possibilities, features of a pathology and resources of the patient' organism.
Kshivets002 2 years ago 74
The USA and Japan are very far, but Switzerland is nearby. May we direct the patients from Switzerland?
swissklin 2 years ago 291
Yes, send patients with documents in English.
Kshivets002 2 years ago 36
What about patients with esophageal and cardioesophageal cancers fom Japan? Can we send them to you?
nakaymajnci 2 years ago 333
See my website.
Kshivets002 2 years ago 35
Dear Dr. Oleg Kshivets:
What about your address?
sfghedsurg 2 years ago 54
Yes, sure! Esophageal and cardioesophageal cancer surgery demands masterly, precise and aggressive surgical technique, especially for cancer with stage T3-4N0-M1A and always will remain privilege of very experienced surgeons. Actual surgical removal of tumor and lymph node metastases remains basic management of this very aggressive cancer giving real chance for cure in spite of extensive research over last 30 years in terms of chemotherapy, radiotherapy, immuno- and gene therapy.
Kshivets002 2 years ago 284
What about the esophageal and cardioesophageal cancer surgery for the patients from the USA?
navycentersurgery 2 years ago 441
Yes, fine qualifications!
mayoclinicsjohn 2 years ago 234
Top professional!
clevelandcliniccts 2 years ago 346
Similar situation in the USA. Today the natural professionals remains no more than 5 which all is in advanced age.
jhsmiamijohn 2 years ago 677
Esophageal cancer is great problem in the UK. Practically all patients die because of esophageal cancer surgery has left the Great Britain.
rbhtpoldan 2 years ago 592
I advise to read 2 articles of Kshivets regarding esophageal & cardioesophageal cancer treatment on the Internet: The Open Cardiovascular and Thoracic Surgery Journal
frankdallason 2 years ago 340
I like VATS, robotic and transhiatal esophagectomies which are optimal for early cancer and adequate in absence of N1 (stage I-IIA: T2-3N0). But these procedures are insufficient for stage IIB-IVA because of problems with lymphadenectomy, etc. Here Ivor-Lewis and Garlock procedures are optimal. Regarding local advanced esophageal/ cardioesophageal cancer it is quite clear: only Ivor-Lewis and Garlock, usually combined, which demand faultless surgical technics and personal wide experience.
Kshivets002 2 years ago 192
I know that Dr. Kshivets is the expert regarding esophagus cancer. May I ask question to Dr. Kshivets: What about minimal invasive and transchiatal esophagectomy for esophagus cancer?
parkerjohncan 2 years ago 339
Yes, I agree with comment. Esophageal and cardioesophageal cancer increased by 500% in last 30 years, but total 5-year survival is only 4% (USA). 80-90% patients with this cancer have already advanced cancer. Only several best surgeons in the world are capable to fulfil such operations successfully.
nsymonc 2 years ago 350
Patients with esophageal cancer with stage IVA live several weeks and die from haemorrhage, generalization, cachexia in spite of chemiotherapy and radiotherapy.
This is perfect surgery of best world level!
alenshow1 2 years ago 337